Molecular Formula | C38H50O6 |
Molar Mass | 602.8 |
Density | 1.114±0.06 g/cm3(Predicted) |
Melting Point | 132 °C |
Boling Point | 710.8±60.0 °C(Predicted) |
Specific Rotation(α) | -143 (c, 0.01 in CHCl3) |
Solubility | Soluble in methanol, ethanol, DMSO and other organic solvents |
Appearance | Light yellow to yellow (Solid) |
Color | Yellow |
pKa | 4.50±1.00(Predicted) |
Storage Condition | -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month. Garcinol is prone to oxidation. Protect from exposure to air. |
MDL | MFCD03700761 |
biological activity | Garcinol is a kind of polyisoprenyl benzophenone extracted from Garcinia indigotica, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) have anticholinesterase properties with IC50 of 0.66 μm and 7.39 μm, respectively. Garcinol also inhibited histone acetyltransferase (HATs, IC50 = 7 μm) and p300/CPB-related factors (PCAF, IC50 = 5 μm). Garcinol has anti-inflammatory and anti-cancer activity. |
Cell Line: | CAL27 and UMSCC1 cells CAL27 and UMSCC1 cells CAL27 cells |
Concentration: | 10, 25, 50 µM 10, 25, 50 µM 50 µM |
Incubation Time: | 24, 48, and 72 hours 24, 48, and 72 hours 1, 2, 4, 6 hours |
Result: | Inhibited the proliferation of two HNSCC cell lines in a time- and dose-dependent manner. Induced apoptosis in HNSCC cells. Suppressed phosphorylation and degradation of the constitutive IκBα in a time-dependent manner. Induced significant inhibition of tumor growth. |
Animal Model: | Five-week-old athymic nu/nu male mice bearing subcutaneous CAL27 tumors |
Dosage: | 1 and 2 mg/kg |
Administration: | I.p.; five times/week for 4 consecutive weeks |